Roflumilast Tablet
Product Images NDC 0904-7399

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Roflumilast (NDC 0904-7399). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Roflumilast-500mcg-30s-cntr-label (Roflumilast 500mcg 30s Cntr Label)

Roflumilast-500mcg-30s-cntr-label (Roflumilast 500mcg 30s Cntr Label)
This is a description for a medication called Roflumilast Tablets. The recommended dosage is one tablet (500 mcg) taken orally once a day for adults. It is important to dispense the accompanying Medication Guide to each patient. The medication should be stored at a temperature range of 20°C-25°C (68°-77°F), with excursions permitted to 15°C-30°C (59°-86°F). The manufacturer is MSN Pharmaceuticals Inc. located in Piscataway, NJ, and the medication is distributed by MAJOR'PHARMACEUTICALS in Indianapolis, IN. The Medication Guide is available for reference.*
FDA Label Image

Roflumilast-500mcg-90s-cntr-label (Roflumilast 500mcg 90s Cntr Label)

Roflumilast-500mcg-90s-cntr-label (Roflumilast 500mcg 90s Cntr Label)
Roflumilast Tablets are a prescription medication used in adults for the treatment of certain lung conditions. Each tablet contains 500 mcg of the active ingredient. The recommended dose is one tablet taken orally once a day. Make sure to provide the accompanying Medication Guide to each patient. The tablets should be stored at a temperature between 20°C-25°C (68°77°F), with slight excursions permitted to 15%-30°C (59" to 86°F) according to USP guidelines. Keep the medication out of reach of children. Roflumilast Tablets are manufactured by MSN Pharmaceuticals Inc. and distributed by MAJOR® PHARMACEUTICALS in Indianapolis, USA. For more information, visit www.majorpharmaceuticals.com or refer to the package insert for complete Prescribing Information.*
FDA Label Image

Roflumilast-fig1 (Roflumilast Fig1)

Roflumilast-fig1 (Roflumilast Fig1)
The text provides information about drug interactions and recommendations for dosage adjustments. It mentions several drugs such as Cimetidine, Enoxacin, Fluvoxamine, Ketoconazole, Minulet, Erythromycin, Budesonide, Digoxin, Formoterol, Maalox, Midazolam, Montelukast, Salbutamol, Sildena, Theophylline, Warfarin, Rifampicin, and Roflumilast. It indicates whether a drug should be used with caution, requires no dose adjustment, or is not recommended.*
FDA Label Image

Roflumilast-structure (Roflumilast Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.